Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.

Pharmaceutical statistics

Volumn 13, Issue 1, 2014, Pages 25-40

  Gamalo, Meg A ^a   Tiwari, Ram C ^b   LaVange, Lisa M ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BAYES THEOREM; CLINICAL TRIAL (TOPIC); DIRICHLET PROCESS PRIOR; HUMAN; META ANALYSIS; META ANALYSIS (TOPIC); METHODOLOGY; NON-INFERIORITY MARGIN; POWER PRIOR; SAMPLE SIZE; SAMPLE-SIZE ESTIMATION;

DIRICHLET PROCESS PRIOR; META-ANALYSIS; NON-INFERIORITY MARGIN; POWER PRIOR; SAMPLE-SIZE ESTIMATION;

ANTI-INFECTIVE AGENTS; BAYES THEOREM; CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84907955316     PISSN: None     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1588     Document Type: Article

References (0)